产品详情
Targets
Target | Value |
---|---|
HER2 | IC50: 59nM |
EGFR | IC50: 92nM |
KDR | IC50: 800nM |
Src | IC50: 1.4μM |
PDK-1 | IC50: >5μM |
IKK2 | IC50: >9μM |
CDK2/CyclinE | IC50: >18μM |
CDK1/CyclinB1 | IC50: >18μM |
C-Raf/MEK1 | IC50: >18μM |
Tpl-2 | IC50: >18μM |
Akt | IC50: >20μM |
c-Met | IC50: >35μM |
MK2 | IC50: >45μM |
CDK4/CyclinD1 | IC50: >50μM |
In vitro (25°C) | DMSO | Warmed: 4 mg/mL (7.18 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.95 mL | 89.77 mL | 179.53 mL |
0.5 mM | 3.59 mL | 17.95 mL | 35.91 mL |
1 mM | 1.8 mL | 8.98 mL | 17.95 mL |
5 mM | 0.36 mL | 1.8 mL | 3.59 mL |
*The above data is based on the productmolecular weight 557.0 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10638 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 557.0 |
Formula | C30H29ClN6O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 698387-09-6 |
SMILES | CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C |
产品标签
Product Questions
Product Questions
Erlotinib HCl
Erlotinib hydrochloride是一种可逆的酪氨酸激酶抑制剂,作用于表皮生长因子受体(EGFR)。
BMS 599626 (AC480)
BMS 599626 (AC480)是一种选择性的,高效效的HER1,HER2和HER4酪氨酸激酶抑制剂(IC50分别为22、32和190 nM),具有…
AZD-9291 (Osimertinib)
AZD-9291 (Osimertinib)是第三代EGFR抑制剂,在临床前研究中显示出希望,并为已对现有EGFR抑制剂产生耐药性的…
Lapatinib (free base)
Lapatinib (free base)是一种双重酪氨酸激酶抑制剂,是一种有效的EGFR和ErbB2抑制剂,在无细胞试验中IC50分别为1…